Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03GRD
|
||||
Former ID |
DIB011894
|
||||
Drug Name |
AX-200
|
||||
Synonyms |
Filgrastim (stroke, ALS), Sygnis; Granulocyte colony stimulating factor (stroke, ALS), Sygnis; Granulocyte colony stimulating factor (intravenous, peripheral arterial occlusive disease/spinal cord injury/stroke/Parkinsons disease), Axaron; G-CSF (protein recombinant/iv, stroke/ALS/PAO/PD/SCI), Sygnis
|
||||
Indication | Cardiovascular disorder [ICD10:I00-I99] | Phase 2 | [521663] | ||
Company |
SYGNIS Bioscience GmbH & Co KG
|
||||
Target and Pathway | |||||
Target(s) | Macrophage colony-stimulating factor receptor | Target Info | Modulator | [532461] | |
NetPath Pathway | Leptin Signaling Pathway | ||||
RANKL Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.